We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+13.07%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$246M
AUM Growth
-$60.8M
Cap. Flow
-$70.1M
Cap. Flow %
-28.47%
Top 10 Hldgs %
67.39%
Holding
78
New
29
Increased
8
Reduced
16
Closed
23

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$13.8M
2
MRK icon
Merck
MRK
+$12.9M
3
SBRA icon
Sabra Healthcare REIT
SBRA
+$5.57M
4
CI icon
Cigna
CI
+$4.93M
5
ELV icon
Elevance Health
ELV
+$4.91M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$15.9M
2
TAK icon
Takeda Pharmaceutical
TAK
+$14.3M
3
BAX icon
Baxter International
BAX
+$12.6M
4
LLY icon
Eli Lilly
LLY
+$12.4M
5
QGEN icon
Qiagen
QGEN
+$12.2M

Sector Composition

Rank Sector Weight
1 Healthcare 73.98%
2 Real Estate 2.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RETA
76
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-24,352
Closed -$612K
1 2 3
4

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Endurant Capital Management held 78 positions worth $246M, down 20% from $307M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Endurant Capital Management withdrew a net $70.1M in Q4 2022, closing 23 positions and reducing 16 holdings. Its most notable exit was Humana, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, down from 77% a quarter earlier, followed by Real Estate.

Against the trend, Endurant Capital Management opened a new position in Centene worth $13.8M.

  • Endurant Capital Management's largest Q4 2022 buy was Centene: 168,363 shares worth $13.8M.
  • Endurant Capital Management added most to Cigna in Q4 2022, an estimated $4.93M increase.
  • Endurant Capital Management's biggest Q4 2022 reduction was Baxter International, cutting an estimated $12.6M.
  • Endurant Capital Management fully exited Humana in Q4 2022, selling an estimated $15.9M.
  • Endurant Capital Management's ten largest holdings make up 67% of its $246M portfolio in Q4 2022.
  • Endurant Capital Management opened 29 new positions and closed 23 in Q4 2022.
  • Endurant Capital Management's portfolio value fell 20% quarter-over-quarter to $246M.

Based on Endurant Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.